ACTIVATION OF TUMORICIDAL PROPERTIES IN MONOCYTES FROM CANCER-PATIENTS FOLLOWING INTRAVENOUS ADMINISTRATION OF LIPOSOMES CONTAINING MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE

被引:0
|
作者
KLEINERMAN, ES [1 ]
MURRAY, JL [1 ]
SNYDER, JS [1 ]
CUNNINGHAM, JE [1 ]
FIDLER, IJ [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,HOUSTON,TX 77030
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4665 / 4670
页数:6
相关论文
共 16 条
  • [1] ACTIVATION OF TUMORICIDAL PROPERTIES IN HUMAN-BLOOD MONOCYTES BY LIPOSOMES CONTAINING LIPOPHILIC MURAMYL TRIPEPTIDE
    KLEINERMAN, ES
    ERICKSON, KL
    SCHROIT, AJ
    FOGLER, WE
    FIDLER, IJ
    [J]. CANCER RESEARCH, 1983, 43 (05) : 2010 - 2014
  • [2] PHASE-I TRIAL OF LIPOSOMAL MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE IN CANCER-PATIENTS
    MURRAY, JL
    KLEINERMAN, ES
    CUNNINGHAM, JE
    TATOM, JR
    ANDREJCIO, K
    LEPEZUNIGA, J
    LAMKI, LM
    ROSENBLUM, MG
    FROST, H
    GUTTERMAN, JU
    FIDLER, IJ
    KRAKOFF, IH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1915 - 1925
  • [3] A DRIED PREPARATION OF LIPOSOMES CONTAINING MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE AS A POTENT ACTIVATOR OF HUMAN-BLOOD MONOCYTES TO THE ANTITUMOR STATE
    SONE, S
    UTSUGI, T
    TANDON, P
    OGAWARA, M
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1986, 22 (03) : 191 - 196
  • [4] ACTIVATION OR SUPPRESSION OF THE TUMORICIDAL PROPERTIES OF MONOCYTES FROM CANCER-PATIENTS FOLLOWING TREATMENT WITH HUMAN RECOMBINANT GAMMA-INTERFERON
    KLEINERMAN, ES
    KURZROCK, R
    WYATT, D
    QUESADA, JR
    GUTTERMAN, JU
    FIDLER, IJ
    [J]. CANCER RESEARCH, 1986, 46 (10) : 5401 - 5405
  • [5] ACTIVATION OF TUMORICIDAL PROPERTIES OF CANCER-PATIENTS MONOCYTES ON FRESH AUTOLOGOUS TUMOR-CELLS
    GALLIGIONI, E
    QUAIA, M
    CRIVELLARI, D
    SPADA, A
    VOLPE, R
    MONFARDINI, S
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 372 - 372
  • [6] INSITU ACTIVATION OF TUMORICIDAL PROPERTIES IN MURINE ALVEOLAR MACROPHAGES FOLLOWING THE SYSTEMIC ADMINISTRATION OF MURAMYL DIPEPTIDE ENCAPSULATED WITHIN LIPOSOMES
    FOGLER, WE
    FIDLER, IJ
    [J]. FEDERATION PROCEEDINGS, 1981, 40 (03) : 761 - 761
  • [7] MACROPHAGE ACTIVATION FOR TUMORICIDAL PROPERTIES BY ACETYLATED LOW-DENSITY-LIPOPROTEIN CONTAINING LIPOPHILIC MURAMYL TRIPEPTIDE
    FUTCH, WS
    SHAW, JM
    SCHOOK, LB
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1986, 40 (03) : 253 - 253
  • [8] ACTIVATION OF COLON CANCER-PATIENTS MONOCYTES BY LYMPHOKINES AND MURAMYL DIPEPTIDE (MDP)
    MAZUMDER, A
    FOGLER, W
    JESSUP, JM
    FIDLER, IJ
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 306 - 306
  • [9] INITIAL CLINICAL-TRIAL OF THE MACROPHAGE ACTIVATOR MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ENCAPSULATED IN LIPOSOMES IN PATIENTS WITH ADVANCED CANCER
    CREAVEN, PJ
    COWENS, JW
    BRENNER, DE
    DADEY, BM
    HAN, T
    HUBEN, R
    KARAKOUSIS, C
    FROST, H
    LESHER, D
    HANAGAN, J
    ANDREJCIO, K
    CUSHMAN, MK
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (05): : 492 - 498
  • [10] SYNERGISM OF RECOMBINANT HUMAN INTERFERON-GAMMA WITH LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE IN ACTIVATION OF THE TUMORICIDAL PROPERTIES OF HUMAN-MONOCYTES
    SONE, S
    TANDON, P
    UTSUGI, T
    OGAWARA, M
    SHIMIZU, E
    NII, A
    OGURA, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (04) : 495 - 500